Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial

✍ Scribed by Cudkowicz, Merit E; van den Berg, Leonard H; Shefner, Jeremy M; Mitsumoto, Hiroshi; Mora, Jesus S; Ludolph, Albert; Hardiman, Orla; Bozik, Michael E; Ingersoll, Evan W; Archibald, Donald; Meyers, Adam L; Dong, Yingwen; Farwell, Wildon R; Kerr, Douglas A

• Book ID: 121301320
• Publisher: The Lancet
• Year: 2013
• Tongue: English
• Weight: 278 KB
• Volume: 12
• Category: Article
• ISSN: 1474-4465
• DOI: 10.1016/S1474-4422(13)70221-7